Introduction
During the development of multicellular organisms, numerous cell-to-cell interactions are required for proper cell fate specification. In both vertebrates and invertebrates, Notch signaling is an evolutionarily conserved mechanism important in cell fate determination and patterning of organ development by restricting or altering a particular cell fate through inductive and lateral signaling (Artavanis-Tsakonas et al., 1999) . Initially discovered in Drosophila melanogaster, where haploid insufficiency results in notching at the wing margin, the Notch gene encodes a large (300 kDa), single-pass, type I transmembrane receptor. In mammals, four members of the Notch family have been identified, Notch1/TAN1, Notch2, Notch3 and Notch4. The elements important for Notch activity include the large extracellular domain, mediating ligand interaction, composed of over 30 EGF-like repeats, three cysteinerich Notch/LIN-12 repeats and six tandem ankyrin or CDC10 repeats. Upon ligand binding, the protein is cleaved, generating the intracellular domain containing the CDC10 repeats that localizes to the nucleus resulting in gene transcription. Although the important role of the Notch family in development is well established, recent studies implicate the Notch pathway in tumorigenesis as well. Human Notch1/TAN1 (translocation associated neoplasia 1) was initially identified through analysis of the t(7;9)(q34;q34.3) chromosomal translocation found in a small subset of acute human T-cell lymphoblasic leukemia/lymphomas (T-ALL) where the translocation results in expression of the intracellular, constitutively activated domain (Ellisen et al., 1991) . In vivo expression of Notch1 can induce T-cell tumors in mice strongly supporting the role of the Notch signaling pathway in oncogenesis (Guan et al., 1996; Pear et al., 1996; Shelly et al., 1999) . Subsequently, other Notch family members have been implicated in cancer (Rohn et al., 1996; Capobianco et al., 1997; Gallahan and Callahan, 1997; Bellavia et al., 2000) .
Inherited mutations in the extracellular domain of Notch3 in humans cause the CADASIL syndrome, a cerebral autosomal dominant adult onset arteriopathy that leads to early stroke and dementia (TournierLasserve et al., 1993; Joutel et al., 1996) . These mutations result in the accumulation of the 216 kDa ectodomain, a proteolytic product, in the smooth muscle cell layer of the cerebral vasculature (Joutel et al., 2000) . The mechanism by which this accumulation results in the CADASIL arteriopathy has yet to be determined. Similar to other Notch family members and their role in development, when Notch3 is constitutively activated, it can alter cellular fate in several organs, including brain and pancreas when expressed behind Ipf1/Pdx and nestin promoters, respectively (Lardelli et al., 1996; Apelqvist et al., 1999) . In addition, Notch3 can also induce T-cell leukemia/lymphoma in a transgenic model driven by the lck promoter (Bellavia et al., 2000) .
We previously have observed overexpression of Notch3 in a subset of human adenocarcinoma (Dang et al., 2000) . Very little is known about the role of Notch3 in cancer of the lung, but in the developing lung Notch3 is expressed throughout the mesenchyme. Some transcripts are detected at a low level in the endoderm as early as E13 (Post et al., 2000) . However, as the lung matures, Notch3 expression is restricted to the smooth muscle layer of arterial blood vessels (Villa et al., 2001 ). Notch1 and Jagged1 transcripts can be detected in the developing epithelium of the airways as early as E11, whereas the expression of Delta1, another ligand for Notch1, is detected in foci of the developing bronchi when examined on E15.5 (Beckers et al., 1999; Taichman et al., 2002) . Mammalian homolog of achaete-scute complex (Mash1), a component of the Notch signaling pathway, is required for the normal differentiation of the pulmonary neuroendocrine cells, and its constitutive expression promotes airway dysplasia and neuroendocrine tumors (Ito et al., 2000; Linnoila et al., 2000) . Hence, there is substantial evidence that the Notch signaling pathway plays an important role in lung development as well as in oncogenesis.
Recent evidence demonstrating the expression of the Notch pathway components in the developing lung and the aberrant overexpression of Notch3 in pulmonary adenocarcinoma suggest that this pathway maybe important for normal maturation of the lung and that alteration in this pathway may play a role in lung cancer. To further clarify the effects of ectopic expression of Notch3 in maturing peripheral pneumocytes, in this study the Notch3 intracellular domain was expressed under the control of the human SP-C promoter in transgenic mice. We observed altered lung morphogenesis and terminal sac morphology with the inhibition of terminal differentiation where there is a failure of the type I pneumocytes to differentiate from type II pneumocytes. Furthermore, although some maturation of type II pneumocytes was observed, the majority of epithelial cells lining the developing alveolar space were undifferentiated. Although the severity of developmental alteration of the lung resulted in perinatal mortality, the arrested differentiation we observed supports a potential role for Notch3 in lung carcinogenesis.
Results

Generation of SP-C-N3IC transgenic mice
We generated a mouse model that constitutively expressed the activated domain of Notch3 throughout the peripheral lung epithelium using the 3.7 kb SP-C promoter ( Figure 1a ). Surfactants are expressed in Type II pneumocytes, precursors to many adenocarcinomas of the lung. Of the 44 potential founder mice born, four died at birth. When screened by PCR, one of the pups bore the transgene. None of the surviving animals harbored the N3IC transgene. As a result of the crucial role of the Notch family in development, the transgenic mice were killed prior to birth, at E18.5, representing the saccular stage of lung development. Of the 182 embryos at E18.5 gestation collected from 32 pregnant mothers, 10 were transgenics, as determined by PCR and Southern blot analysis (Figure 1b ).
Notch3 alters lung morphogenesis in transgenic embryos
In the mouse, lung development begins with the evagination of the lung primordium budding from the ventral foregut into the surrounding splanchnic mesoderm, at about embryonic day 9.5. The process of branching morphogenesis, a series of elongation and reiterated branching of the lung buds that give rise to the pulmonary tree, begins at E10.5. By E18.5 the branching pattern is complete, whereas the process of alveolization continues postnatally (for a review see Hogan (1999) , Warburton et al. (2000) ). In our study, the gross appearance and size of the SP-C-N3IC embryos are similar to their control littermates. However, in the histological examination of the E18.5 mice, abnormal morphology was noted in lungs from the 10 transgenics SP-C-N3IC mice. These mice expressed varying degrees of lung morphologic abnormalities, from diffuse, dilated sacculi where the number of acinar buds and sacculi were decreased (Figure 3b ) to discrete regions of abnormal tubular formation with increased numbers Figure 3a) . In both phenotypes, the terminal lung epithelium demonstrates diffuse metaplasia, composed mostly of undifferentiated cuboidal cells (Figures 2b, c and 3 and 3) . In contrast, the control lungs showed normal extensive branching with differentiating sacculi and appropriate thinning of the developing alveolar wall (Figure 2a, c) . There is also heterogeneity in the amount of supporting mesenchyme, but still denser than what was seen in their littermate controls (Figures 2 and 3) .
Expression of the Notch3 and SP-C-N3IC transgene
In situ hybridization demonstrated that the ectopic expression of Notch3 mRNA was mostly located in the peripheral epithelium in transgenics as compared to wild-type littermates (Figure 4 ). In contrast, endogenous Notch3 expression is detected in a blood vessel in wildtype control ( Figure 4a , b, arrows) consistent with previous studies (Joutel et al., 2000; Villa et al., 2001 ). The SV40 t-intron polyadenylation fragment (tPA) was used to synthesize riboprobes for detecting transgenespecific expression in our E18.5 mice ( Figure 5 ).
Transgenic mRNA was detected only in the epithelial cells with abnormal morphology and not in areas that appear normal (Figure 5c, d, arrows) . The pattern of expression is most prominent in the lung peripheral epithelium, consistent with previous published studies of transgenic mice bearing the SP-C promoter constructs (Glasser et al., 1991; Wert et al., 1993; Zhou et al., 1997; Zeng et al., 2001 ).
Notch3 expression inhibits terminal differentiation at the level of fetal respiratory epithelium
The maturation of distal, cuboidal epithelium of the terminal acinar tubule into type I and type II cells that is critical for respiration, begins from about E16.6 and continues well after birth. The extensive branching morphogenesis and alveolization, coupled with vasculogenesis ultimately form the mature pulmonary system for gas exchange with the circulation (reviewed in Hogan (1999) , Ten Have-Opbroek (1991)). As lung development progresses from the canalicular stages (E16.6-E17.4) to the saccular stage (E17.4-postnatal day 5), peripheral airways form the typical terminal Thus, it is possible that perturbation in vasculogenesis does not occur because of the specific promoter-driven expression distribution.
To characterize the cell population in the SP-C-N3IC transformed epithelium, immunohistochemical staining of several lung epithelial proteins was assessed. The intensity of staining with surfactant protein markers, pro-SP-C and SP-B, was markedly decreased compared to littermate controls (Figure 6a, b, arrows) . On the other hand, markers for Clara cell secretory protein (Figure 6c ) and calcitonin-gene-related peptide (data not shown) showed normal expression in distal bronchial epithelium but not in the abnormal, cuboidal cells lining the terminal airways. Thyroid transcription factor-1 (TTF-1) is a homeodomain protein transcription factor that plays an important role in lung morphogenesis. In mammalian lung development, TTF-1 is expressed in the primordial epithelium of the primary branches of the initial lung bud and continues to be expressed in the developing lung epithelium. With advancing gestational age, TTF-1 staining is most intense in the lung periphery, and by adulthood TTF-1 is expressed primarily in alveolar type II cells. In the present study, all of the cuboidal cells from the affected lungs at E18.5, show intense TTF-1 nuclear staining (Figure 6d ). The majority of the abnormal cuboidal cells fail to express specific cell type markers with exception of TTF-1, supporting the hypothesis that they are undifferentiated respiratory cells.
The ultrastructural analysis of the terminal sacculi of nontransgenic littermates at E18.5 (Figure 7a) showed that the septae were composed of a thin layer of fibroblasts and capillaries, with an overlying epithelial layer of type I and type II pneumocytes. In contrast, the peripheral epithelium of transgenic animals ( Figure 7c ) showed immature appearing cuboidal cells and the absence of type I pneumocytes. At higher magnification, Figure 4 Notch3 mRNA localization in fetal lungs using antisense probe to the intracellular domain of Notch3 at E18.5. In situ hybridization shows higher Notch3 expressions in the epithelium of transgenic animals (c, d) as compared to wild-type littermate (a, b). In contrast, Notch3 mRNA expression is seen in arterial blood vessels of controls (arrowheads). Bar ¼ 100 mm Notch3 inhibits terminal differentiation in lung TP Dang et al these cuboidal cells have microvilli, an abundant glycogen pool and multivesicular bodies, without lamellar bodies, suggesting that they are undifferentiated or pre-type II pneumocytes (Figure 7d ). Our data thus suggest that Notch3 not only inhibits type I differentiation, but also leads to metaplasia of undifferentiated respiratory cells. We then examined whether there is an increased proliferation by Ki-67 staining and by the quantitating number of mitoses or change in apoptosis by cleaved caspase-3 staining. There was no difference between transgenics and their control littermates (data not shown).
Discussion
As a result of the involvement of Notch3 in cell fate determination and its overexpression in a subset of human pulmonary adenocarcinomas, we assessed the effect of forcing respiratory-specific activated gene expression in a SP-C-N3IC transgenic model. The present study demonstrates that in vivo expression of activated Notch3 induces dramatic abnormalities of lung morphogenesis and inhibition of type I pneumocyte differentiation leading to perinatal lethality. Lungs from transgenic mice exhibit abnormal ductal formation, dilated sacculi and undifferentiated pneumocyte metaplasia. These findings support the hypothesis that perturbation of this pathway plays a role in the multistep process leading to neoplastic transformation. The morphologic alterations observed included abnormal lung branching morphogenesis as indicated by both tubular proliferation without subsequent dilation during saccular formation and abnormally dilated peripheral sacculi. The appearance of abnormal tubular formation and dilated sacculi suggests that high expression of Notch3 leads to abnormal lung branching morphogenesis. A similar pattern of abnormal epithelial branching can be seen in the Ipf1/Pdx-N3IC transgenic mice, where the activated intracellular domain of Notch3 is placed under a pancreas-specific promoter (Apelqvist et al., 1999) . In these transgenic embryos, the pancreatic epithelium was poorly branched and reduced in size. The variability in branching morphogenesis seen in the SP-C-N3IC transgenics may be a result of the transcription of SP-C gene as early as E10.5, when branching morphogenesis is still occurring, and the differences in the expression among transgenics (Glasser et al., 1991) .
While ectopic Notch3 expression inhibits respiratory epithelial differentiation, no increase in either Ki-67 or the number of mitoses was observed, suggesting that the changes are not related to cell proliferation. There was no observed change in cleaved caspase-3 staining, suggesting that apoptosis does not play a significant role in the expansion of the undifferentiated respiratory epithelium. This observation is consistent with the nestin-N3IC transgenic mouse model where there is an expansion of neural progenitor cells without alteration of the proliferation rate (Lardelli et al., 1996) . The expression patterns of markers specific for the various, mature cell populations in the normal lungs shows that the observed cuboidal cells in the transgenics are essentially undifferentiated or pre-type II epithelium.
The Notch signaling pathway governs cell fate determination by restricting or skewing a particular cell fate choice during development, often through local cellto-cell interactions. In the development of the Drosophila tracheal system, this lateralization allows clusters of equivalent cells to undergo diversification (Llimargas, 1999) . Strong evidence in the human, adult lung suggests that type I pneumocytes are terminally differentiated from type II pneumocytes. Notch3 appears to repress Notch1-mediated HES-1 expression in vitro . Thus, in the pulmonary epithelium of SP-C-N3IC mice, Notch3, similar to Notch1-null mutant, inhibits diversification of a cluster of equivalent cells, resulting in the failure of type II cells to differentiate into type I pneumocytes. Similar results were seen in the Ipf1/Pdx-N3IC transgenic mice, where the pancreas not only demonstrated impaired epithelial proliferation and morphogenesis, but also exocrine epithelium cell differentiation, without perturbing endocrine cell differentiation (Apelqvist et al., 1999) .
The reciprocal interaction between the epithelial primordium and its surrounding mesenchymal tissue is important not only for branching morphogenesis, but also for the differentiation of the pulmonary epithelium (Hogan and Yingling, 1998) . In the SP-C-N3IC mice, the mesenchyme demonstrated an increase in stromal cells without any evidence of fibrosis suggesting that the induced changes in the epithelium affected the maturation of the lung mesenchyme. In the developing lung at E13, Notch3 is expressed throughout the mesenchyme, but by adulthood, its expression is restricted to arterial smooth muscle cells (Joutel et al., 2000; Villa et al., 2001) . Despite the important role of the Notch signaling pathway in vascular development, no alteration in vasculogenesis was observed in the transgenics using the PECAM-1 antibody, suggesting that the mesenchymal differentiation was influenced by the abnormally developing epithelium, and not by alterations of angiogenesis. However, the extent of the contribution of the hyperplasic stromal cells and the potential altered lung matrix to the phenotypic abnormality observed needs further evaluation. The present study indicates that deregulation of Notch3 signaling in the developing lung affects lung morphogenesis and terminal differentiation. In our previous study, we associated the upregulation of Notch3 with a t(15;19) balanced translocation in a Figure 7 Transmission electron microscopy of SP-C-N3IC E18.5 transgenic mice. The developing alveolar epithelium of littermate control (a) containing both type I and type II pneumocytes. The thin cytoplasmic extension of type I cell can be seen overlying an adjacent capillary containing a red blood cell. The peripheral epithelium in the transgenic animal (c) is lined by the more immatureappearing cuboidal cells (arrowheads). A well-differentiated type II pneumocyte from the control littermate (b) shows no glycogen pool and several types of inclusion bodies including multilamellar bodies, considered to be the secretory granules for surfactant secretion. The cuboidal cell (d) lining the peripheral airway of the transgenic embryo contains glycogen pools without any evidence of lamellar bodies related to surfactant production, suggesting a less differentiated cell. I , type I pneumocytes; II, type II pneumocytes; c, capillaries; DIB, dense inclusion bodies; ER, endoplasmic reticulum; g, glycogen; LB, lamellar bodies; m, mitochrondria; mv, microvilli; MVB, multivesicular bodies; RBC, red blood cell. Bars ¼ 2 mm Notch3 inhibits terminal differentiation in lung TP Dang et al human lung adenocarcinoma. We further demonstrated that approximately 25% of adenocarcinomas of the lung showed increased Notch3 expression, supporting the hypothesis that Notch3 is a potential oncogene (Dang et al., 2000) . Prenatal activation of Notch3 in the peripheral epithelium of the lung in our SP-C-N3IC mouse model leads to nonviable newborn pups, making it impossible to evaluate tumor progression. The effect of activation of Notch3 in adult animals is still unknown. Regardless, the ectopic expression of Notch3 appears to inhibit terminal differentiation of type I pneumocytes and results in metaplasia of the immature respiratory epithelium. Normal cells exhibit well-controlled system of proliferation, apoptosis and differentiation that are tightly regulated by numerous extracellular and intracellular signals. The derangement of differentiation by the overexpression of Notch3 may thus contribute to the multistep progress of lung adenocarcinoma formation.
Materials and methods
Generation of SPC-Notch3 transgenic mice
The murine SPC-Notch3 construct was synthesized by subcloning and blunting the 2.0 kb KpnI and NsiI fragment of the Notch3 intracellular domain (N3IC) (a gift from Urban Lendhal at Karolinska Institute, Stockholm, Sweden) into the blunted, unique SalI and EcoRI sites of the human SPCpromoter plasmid SP-C-3.7 SV40 t-intron-polyA (gift from J Whitsett) (Glasser et al., 1991) . The proper orientation of the construct was verified by restriction enzyme digestion and sequencing. The chimeric SP-C-N3IC gene was excised with NdeI and NotI and purified from 1% low-melting agarose using the QIAquick Gel Extraction Kit (Qiagen Inc., Valencia, CA, USA). The purified DNA (3 ng) was injected into the fertilized eggs of B6D2 mice at the Vanderbilt Transgenic/ES Cell facility. The embryos from pregnant mothers were obtained by hysterectomy at embryonic day 18.5 (E18.5). Transgenic founders were identified by PCR analysis and confirmed by Southern blot analysis of tail DNA.
Tissue preparation
Hysterectomy was performed after lethal inhalation of CO 2 . The embryonic lung tissues were dissected and fixed in 4% paraformaldehyde in PBS at 41C overnight. The tissues were dehydrated through a graded series of ethanol solutions, embedded in paraffin and sectioned at 5 mm thickness. The sections were stained with hematoxylin and eosin, processed with immunohistochemistry or in situ hybridization. The proliferation index was measured by counting the number of mitoses per 10 high-power fields at Â 40 magnification with light microscopy.
Antibodies and immunohistochemistry
Immunohistochemical analysis was performed on paraformaldehyde-fixed, paraffin-embedded tissues using a panel of lung-specific antibodies. Following routine deparaffinization including an endogenous peroxidase quench for 15 min at RT with 0.3% H 2 O 2 in methanol, antigen retrieval was performed by heating slides immersed in Trilogy buffer (Cell Marque, Inc.) in a preheated steamer for 25 min followed by a 15 min cool down period. Lung TTF-1 and Ki-67 expression was detected with anti-TTF-1 mouse monoclonal antibodies (Neomarkers, Inc.) at 1 : 50 and MIB-5 (Dako, Inc.) at 1 : 25, respectively, with a MOM (Mouse-on-Mouse kit from Vector Labs, Inc.). Rabbit polyclonal CGRP (Amersham, Inc.), proSP-C (gift from J Whitsett), SP-B (Chemicon International, Inc.), CCSP (gift from J Whitsett), and cleaved caspase-3 (Cell Signaling Technology, Inc.) were used at dilutions of 1 : 3000, 1 : 500, 1 : 100, 1 : 1000 and 1 : 64, respectively, and stained using a Ventana ES automated immunohistochemistry staining system. Staining with PECAM-1 antibodies (Pharmagen, Inc.) required following modifications: Prior to the 15 min incubation with 3% H 2 O 2 in methanol, antigen retrieval was performed using 0.1% trypsin at RT for 15 min. After blocking with 2% normal rabbit serum in phosphate-buffered saline (PBS) with 2% Triton X-100 for 2 h at RT, the primary antibody was applied at 1 : 50 dilution at 41C overnight. The rest of the procedure was performed according to the manufacturer's directions using an anti-Rat Vector Elite ABC kit (Vector Labs, Inc.).
In situ hybridization
Plasmids containing the 453 bp fragment of Notch3 intracellular domain and the 478-bp SV40 t-intron-poly(A) fragment (a gift from J Whitsett) were used to generate antisense and sense riboprobes for Notch3 expression and transgene-specific expression (Zhou et al., 1997) . T7 RNA polymerase and T3 RNA polymerase transcription of linearized plasmids were used to generate a 35 S-labeled UTP (specific activity: >1000 Ci/ mmol, Amersham, Inc.) both sense and antisense riboprobes to SV40 t-intron-poly(A) and Notch3, respectively. Conditions and solutions for hybridization were as previously described (Wert et al., 1993) . Hybridization of both riboprobes was carried out overnight at 551C. The slides were dipped in 50% Ilford K5 nuclear track emulsion in 10% glycerol, dried and autoradiographed for 3 weeks at 41C. Typical examples of hybridization results were photographed with dark-field illumination and counterstained with hematoxylin for brightfield examination and photomicroscopy.
Electron microscopy
Fetal lung tissues no more than 3 mm 2 were fixed in 2.5% gluteraldehyde in 0.1 m phosphate buffer overnight at 41C, washed and stored using 0.1 m phosphate buffer. They were then postfixed in 1% osmium tetroxide in 0.1 m phosphate buffer, washed and dehydrated through ascending alcohols 70-100% ETOH, from 15 min to 1 h for the absolute ETOH. The tissue was then infiltrated with propylene oxide, followed by propylene oxide spurrs (epoxy resin) 1 : 1 overnight, and changed the next day to pure 'Spurrs'. They were embedded in plastic capsules, which were polymerized at a 56-601C overnight. Ultrathin (90 nm) sections were cut with a diamond knife, mounted on uncoated copper mesh grids, counterstained with lead citrate and uranyl acetate and examined with a Phillips CM-12 electron microscope and with an AMT (Advanced Microscopy Techniques Corp. of Danvers, MA, USA) digital camera.
